Skin: Major target organ of allergic reactions to small molecular weight compounds

Toxicology and Applied Pharmacology

Volumn 224, Issue 3, 2007, Pages 313-317

  Merk, Hans F ^a   Baron, Jens M ^a   Neis, Mark M ^a   Obrigkeit, Daniela Höller ^a   Karlberg, Ann Therese ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Contact dermatitis; Drug allergy; Prohapten; Skin metabolism; Xenobiotica

Indexed keywords

FRAGRANCE; SULFONAMIDE;

DRUG ERUPTION; DRUG HYPERSENSITIVITY; HUMAN; MOLECULAR WEIGHT; PATHOPHYSIOLOGY; REVIEW; SKIN ALLERGY; TARGET ORGAN; XENOBIOTIC METABOLISM;

ANIMALS; DERMATITIS, ALLERGIC CONTACT; DRUG ERUPTIONS; HUMANS; MOLECULAR WEIGHT; PERFUME; PHARMACEUTICAL PREPARATIONS; SKIN; XENOBIOTICS;

EID: 35348894297     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.01.004     Document Type: Review

References (63)

1. Ahmad N., and Mukhtar H. Cytochrome P450: a zarget for drug development for skin diseases. J. Invest. Dermatol. 123 (2004) 417-425
2. Ahmad N., Agarwal R., and Mukhtar H. Cytochrome P-450 and drug development for skin diseases. Skin Pharmacol. 9 (1996) 231-241
3. Alsbou M., Rice A., Alfirevic A., Park B.K., and Pirmohamed M. Effect of carbamazepine on expression of the HSP-70 genes in B cells from hypersensitive patients. 2nd International Drug Hypersensitivity Meeting (2006) 24-25 Abstract No. 25
4. Andresen Bergström M., Luthman K., Nilsson J.L.G., and Karlberg A.-T. Conjugated dienes as prohaptens in contact allergy: in vivo and in vitro studies of structure-activity relationships, sensitizing capacity and metabolic activation. Chem. Res. Toxicol. 19 (2006) 760-769
5. Azukizawa H., Kosaka H., Sano S., Itami S., and Katayama I. Animal models of toxivc epidermal necrolysis. 2nd International Drug Hypersensitivity Meeting (2006) 15 Abstract No. 9
6. Baron J.M., Höller D., Schiffer R., Frankenberg S., Neis M., Merk H.F., and Jugert F.K. Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. J. Invest. Dermatol. 116 4 (2001) 541-548 (Apr)
7. Basketter D.A. Skin sensitization to cinnamic alcohol: the role of skin metabolism. Acta. Derm.-Venereol. 72 (1992) 264-265
8. Beaune P., Dansette P.M., Mansuy D., Kiffel L., Finck M., Amar C., Leroux J.P., and Homberg J.C. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 551-555
9. Bergström M.A., Ott H., Carlsson A., Neis M., Zwadlo-Klarwasser G., Merk H.F., Karlberg A.T., and Baron J.M. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J. Invest. Dermatol. 127 (2007) 1145-1153
10. Betrand F., Basketter D.A., Roberts D.W., and Lepoittevin J.P. Skin sensitization to eugenol and isoeugenol in mice: possible metabolic pathways involving ortho-quinone and quinone methide intermediates. Chem. Res. Toxicol. 10 (1997) 335-343
11. Bickers D.R., and Kappas A. Human skin aryl hydrocarbon hydroxylase-induction by coal tar. J. Clin. Invest. 62 (1978) 1061-1068
12. Bickers D.R., Dutta-Choudhury T., and Mukhtar H. Epidermis: a site of drug metabolism in neonatal rat skin. Mol. Pharmacol. 21 (1982) 239-247
13. Chen J., Gou H., Mannargudi M., and Uetrecht J.P. Role of reactive metabolites in Nevirapine-induced skin rash. 2nd International Drug Hypersensitivity Meeting (2006) 35-36 Abstract No. 35
14. Cribb A.E., Pohl L.R., Spielberg S.P., and Leeder J.S. Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins. J. Pharmacol. Exp. Ther. 282 (1997) 1064-1072
15. De Groot A.C., and Frosch P.J. Adverse reactions to fragrances. Contact Dermatitis 36 (1997) 57-86
16. DeSwarte R.D., and Patterson R. Drug allergy. In: Patterson R., Grammer L.C., and Greenberger P.A. (Eds). Allergic Diseases (1997), Lippincott-Raven, Philadelphia 317-412
17. Dreuw A., Hermann H.M., Heise R., Joussen S., Rodriguez F., Marquardt Y., Jugert F.K., Merk H.F., Heinrich P.C., and Baron J.M. Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts. J. Invest. Dermatol. 124 1 (2005) 28-37 (Jan)
18. Du L., Neis M.M., Ladd P.A., Lanza D.L., Yost G.S., and Keeney D.S. Effects of the differentiated keratinocytes phenotype on expression levels of CYP1-4 family genes in human skin cells. Toxicol. Appl. Pharmacol. 213 (2006) 135-144
19. Estrada E., Patiewicz G., and Gutierrez Y. From knowledge generation to knowledge archive. J. Chem. Inf. Comput. Sci. 44 (2004) 688-698
20. Fiszenson-Albala F., Auzerie V., Mahe E., Farinotti R., Durand-Stocco C., Cricks B., and Descamps V. A 6-months prospective survey of cutaneous drug reactions in a hospital settino. Br. J. Dermatol. 149 (2003) 1018-1022
21. Friedman P.S., Pirmohamed M., and Park K. Investigations of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch. Dermatol. 130 (1994) 598-604
22. Greenberger P.A. Drug allergy. J. Allergy Clin. Immunol. 117 (2006) S464-S470
23. Gruchalla R.S., and Pirmohamed M. Antibiotic allergy. N. Engl. J. Med. 354 (2006) 601-609
24. Guengerich F.P. VolCytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J. 8 1 (2006) E101-E111 (Article 12; S)
25. Hertl M., Jugert F., and Merk H.F. CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br. J. Dermatol. 132 (1995) 215-220
26. + T-cells. Toxicology 206 (2005) 221-231
27. Janmohamed A., Dolphin C.T., Phillips I.R., and Shephard E.A. Quantification and cellular localization and expression in human skin of genes encoding flavin-containing monooxygenases and cytochrome P450. Biochem. Pharmacol. 62 (2001) 777-786
28. Karlberg A.T., Bohlinder K., Boman A., Hachsell U., Hermansson J., Jacobsson S., and Nilsson J.L.G. Identification of 15-hydroperoxyabietic acid as a contact allergen in Portuguese colophony. J. Pharm. Pharmacol. 40 (1988) 42-47
29. Karlberg A.T., Shao L.P., Nilsson U., Gäfvert E., and Nilsson J.L.G. Hydroperoxides in oxidized d-limonene identified as potent contact allergens. Arch. Dermatol. Res. 286 (1994) 97-103
30. Kawakubo Y., Merk H.F., Masaoudi T.A., Sieben S., and Blomeke B. N-acetylation of paraphenylenediamine in human skin and keratinocytes. J. Pharmacol. Exp. Ther. 292 1 (2000) 150-155
31. Layland L.E., Wulferink M., Dierkes S., and Gleichmann E. Drug induced autoantibody formation in mice: triggering by primed CD4+CD25- T cells, prevention by primed CD4+CD25+ T cells. Eur. J. Immunol. 34 (2004) 36-46
32. Levin W., Conney A.H., Alvares A.P., Merkatz I., and Kappas A. Induction of benzo(a)pyrene hydroxylase in human skin. Science 176 (1972) 419-420
33. Lilienblum W., Irmscher G., Fusenig N.E., and Bock K.W. Induction of UDP-glucuronyl-transferase and arylhydrocarbon-hydroxylase activity in mouse skin and in normal and transformed skin cells in culture. Biochem. Pharmacol. 35 (1986) 35-42
34. Masson M.J., and Uetrecht J.P. Tolerance induced by low dose d-penicillamine in the brown Norway rat model of drug-induced autoimmunity is immune-mediated. Chem. Res. Toxicol. 17 (2004) 82-94
35. Matura M., Goossens A., Bordalo O., Garcia-Bravo B., Magnusson K., Wrangsjö K., and Karlberg A.-T. Oxidized citrus oil (R-limonene)-A frequent skin sensitizer in Europe. J. Am. Acad. Derm. 47 (2002) 709-714
36. Merk H., Mukhtar H., Kaufmann I., Das M., and Bickers D.R. Human hair follicle benzo(a)pyrene and benzo(a)pyrene 7,8-diol metabolism: effect of exposure to a coal tar-containing shampoo. J. Invest. Dermatol. 88 (1987) 71-76
37. Merk H.F., Dorfmüller A., Sachs B., and Baron J.M. Delayed hypersensitivity reactions. ACI Int. 14 (2002) 194-198
38. Mockenhaupt M. Schwere Hautreaktionen der Haut. Hautarzt 56 (2005) 24-31
39. Mukhtar H., and Bresnick E. Glutathione-S-epoxide transferase in mouse skin and human foreskin. J. Invest. Dermatol. 66 (1976) 161-164
40. Naisbitt D.J., Farrell J., Gordon S.F., Maggs J.L., Burkhart C., Pichler W.J., Pirmohamed M., and Park B.K. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation. Mol. Pharmacol. 62 3 (2002) 628-637
41. Naisbitt D.J., Britschgi M., Farrell J., Wong G., Depta J.P.A., Chadwick D.W., Pichler W.J., Pirmohamed M., and Park B.K. Hypersensitivity reactions to Carbamazepine: characterisation of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. J. Pharmacol. Exp. Ther. 63 (2003) 732-741
42. Naisbitt D.J., Farrell J., Chamberlain P.J., Hopkins J.E., Berry N.G., Pirmohamed M., and Park B.K. Characterisation of the T-cell response in a patient with phenindione hypersensitivity. J. Pharmacol. Exp. Ther. 313 (2005) 1058-1065
43. Nierkens S., and Pieters R. Murine models of drug hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 5 (2005) 331-335
44. Nilsson A.-M., Andresen Bergström M., Luthman K., Nilsson J.L.G., and Karlberg A.-T. A conjugated diene identified as a prohapten: contact allegenic activity and chemical reactivity of proposesd epoxide metabolites. Chem. Res. Toxicol. 18 (2005) 308-316
45. Pichler W.J. Immune mechanisms of drug hypersensitivity. Immunol. Allergy Clin. North Am. 24 (2004) 373-397
46. Pirmohamed M. Genetic factors in the predisposition to drug-induced hypersensitivity reactions. AAPS J. 8 1 (2006) E20-E26 (Article 3; S)
47. Pirmohamed M., and Atuah K.N. Pharmacogenetics and adverse drug reactions. In: Lee A. (Ed). Adverse Drug Reactions (2006), Pharmaceutical Press, London 43-73 2. Aufl.
48. Popovic M., Caswell J., and Uetrecht J.P. A study of the sequence of events involved in nevirapine-induced skin rash in brown norway rats. 2nd International Drug Hypersensitivity Meeting (2006) 13-14 Abstract No. 6
49. Reilly T.P., Lash L.H., Doll M.A., Hein D.W., Woster P.M., and Svensson C.K. A role for bioactivation and covalent binding within epidermal keratinocytes in sulphonamide-induced cutaneous drug reactions. J. Invest. Dermatol. 114 (2000) 1164-1173
50. Roychowdhury S., Vyas P.M., Reilly T.P., Gaspari A.A., and Svensson C.K. Characterisation of the formation and localisation of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J. Pharm. Exp. Ther. 314 (2005) 43-52
51. Sanderson J.P., Naisbitt D.J., Farrell J., Drummond N., Mathews K.L., Pirmohamed M., Clarke S.E., and Park B.K. Dendritic cell metabolism of sulfamethoxazole leads to increased CD40 expression. 2nd International Drug Hypersensitivity Meeting (2006) 16 Abstract No. 10
52. Sanderson J.P., Naisbitt D.J., and Park B.K. Role of bioactivation in drug-induced hypersensitivity reactions. AAPS J. 8 1 (2006) E55-E64 (Article 7; S)
53. Schiffer R., Neis M., Höller D., Rodriguez F., Geier A., Gartung C., Lammert F., Dreuw A., Zwadlo-Klarwasser G., Merk H.F., Jugert F.K., and Baron J.M. Active influx transport is mediated by members of the organic anion transporting polypeptide family in human epidermal keratinocytes. J. Invest. Dermatol. 120 2 (2003) 285-291 (Feb)
54. Shenton J.M., Chen J., and Uetrecht J.P. Animal models of idiosyncratic drug reactions. Chem. -Biol. Interact 150 (2004) 53-70
55. Sieben S., Hertl M., Al Masaaoudi P., Merk H.F., and Blömeke B. Characterization of T cell responses to fragrances. Toxicol. Appl. Pharmacol. 172 (2001) 172-178
56. Sieben S., Kawakubo Y., Massaoudi T.A., Merk H.F., and Blömeke B. Delayed-type hypersensitivity reaction to paraphenylendiamine is mediated by 2 different pathways of antigen recognition by specific αβ+human T-cell clones. J. Allergy Clin. Immunol. 109 (2002) 1005-1011
57. Sköld M., Börje A., Harambasic E., and Karlberg A.-T. Contact allergens formed on air exposure of linalool. Identification and quantification of primary and secondary products and the effect on skin sensitization. Chem. Res. Toxicol. 17 (2004) 1697-1705
58. Smith C.K., Moore C.A., Elahi N.E., Smart A.T.S., and Hotchkiss A.M. Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol. Toxicol. Appl. Pharmacol. 168 (2000) 189-199
59. Uetrecht J. Role of animal models in the study of drug-induced hypersensitivity reactions. AAPS J. 7 4 (2006) E914-E992 (Article 89; S)
60. Vyas P.M., Roychowdhury S., Khan F.D., Prisinzano T.E., Lamba J., Schuetz E.G., Blaisdell J., Goldstein J.A., Munson K.L., Hines R.N., and Svensson C.K. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochrome P450. J. Pharmacol. Exp. Ther. 319 1 (2006) 488-496
61. Vyas P.M., Roychowdhury S., Koukouritaki B., Hines R.N., Krueger S.K., Williams D.E., Nauseef W.M., and Svensson C.K. Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases. J. Pharmacol. Exp. Ther. 319 1 (2006) 497-505
62. Weiss M.E. Drug allergy. Med. Clin. North Am. 76 (1992) 857-882
63. Wolkenstein P., Tan C., Lecoeur S., Wechsler J., Garcia-Martin N., Charue D., Bagot M., and Beaune. Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. Chem. -Biol. Interact. 113 (1998) 39-50